Premium
Serum lipids during oral contraceptive exposure
Author(s) -
Corredor D. G.,
Mendelsohn L. V.,
Sabeh G.,
Sunder J. H.,
Danowski T. S.
Publication year - 1970
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1002/cpt1970112188
Subject(s) - mestranol , norethynodrel , medicine , lipoprotein , chlormadinone acetate , endocrinology , physiology , population , cholesterol , research methodology , family planning , environmental health
The serum total cholesterol did not change significantly du ring 6 to 60 months of exposure to an oral contraceptive steroid combination (mestranol and norethynodrel). Alpha lipoprotein levels increased and remained slightly elevated. Serum total triglycerides increased during the sixth to eighteenth month of exposure only.